Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications With the US Food and Drug Administration
| Autor: | Daniel W Sigelman, Peter Lurie, Anam H Chaudhry, Harinder Singh Chahal, Stella Kim, David Szeto |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Drug
File (record) business.industry media_common.quotation_subject 010102 general mathematics Internet privacy MEDLINE Biosimilar 01 natural sciences Food and drug administration 03 medical and health sciences 0302 clinical medicine Biosimilar Pharmaceuticals Internal Medicine Research Letter Medicine 030212 general & internal medicine Public disclosure 0101 mathematics business License media_common |
| Zdroj: | JAMA Intern Med |
| ISSN: | 2168-6114 |
| Popis: | This cross-sectional study reviews New Drug Applications for new molecular entities and Biologics License Applications for new and biosimilar biological products submitted to the US Food and Drug Administration to assess how frequently applicants disclose applications in the media. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|